Skip to content

Strides Pharma Q3 consolidated net loss at Rs 82 crore

Revenue from operations rose to Rs 865 crore for the quarter under review as against Rs 794 crore in the year-ago period

Read More

​ Revenue from operations rose to Rs 865 crore for the quarter under review as against Rs 794 crore in the year-ago period Revenue from operations rose to Rs 865 crore for the quarter under review as against Rs 794 crore in the year-ago period  Moneycontrol Latest News Read More  

Leave a Reply

Generated by Feedzy
en_USEnglish
%d bloggers like this: